Clinical trial
Treatment With AX200 for Acute Ischemic Stroke
NCT00132470 · Axaron Bioscience AG, Industry · Completed
Key facts
| NCT number | NCT00132470 |
|---|---|
| Title | Treatment With AX200 for Acute Ischemic Stroke |
| Official title | AXIS IIa - Treatment With AX200 for Acute Ischemic Stroke |
| Lead sponsor | Axaron Bioscience AG, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebral Stroke |
| Intervention type | Drug |
| Interventions | AX200 (G-CSF) |
| Enrollment | 42 |
| Start date | Dec 1, 2004 |
| Completion | Mar 1, 2007 |
| First posted | Aug 22, 2005 |
| Last update posted | Jul 25, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: